Immunity directed against MSP 2 during anaplasmosis
Immunity directed against MSP 2 during anaplasmosis
批准号:
6741510
负责人:
JEFFREY R ABBOTT
金额:
$4.64万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-05-01 至 2005-01-01
关键词:
B lymphocyteRickettsialesRickettsiales diseaseantibacterial antibodyantibody titeringbacterial antigensbacterial proteinsbacterial vaccinescomplementary DNAcowhelper T lymphocyteimmunotherapyleukocyte activation /transformationmembrane proteinsmicroorganism immunologymolecular cloningnonhuman therapy evaluationrecombinant proteinsticksvaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Agents of the tribe Ehrlichiae cause a
variety of tick-borne diseases in both humans and animals. Many of these
agents persist in the host thus acting as potential reservoirs for further
spread of disease. Anaplasma marginale is closely related genetically (16S
rRNA) with E. phagocytophila, the causative agent of human granulocytic
ehrlichiosis (HGE). Indeed, both organisms express antigenically variant outer
membrane proteins, major surface protein-2 (MSP-2) that share significant
amino acid sequence conservation characterized by highly conserved N and C
terminal regions and a central, hydrophilic, hypervariable region. Levels of
rickettsemia during persistent anaplasmosis are approximately two orders of
magnitude less than rickettsemia levels during acute infection and do not
result in clinical disease. We hypothesize that the control of rickettsemia to
levels significantly below those observed during acute clinical anaplasmosis
is due to a memory CD4+ Th-cell response to conserved epitopes on MSP-2 that
enhance variant specific B cell responses directed against the hypervariable
region. The results of this research will provide insight into means of
developing outer membrane protein-based vaccines against A. marginale and
other ehrlichial organisms that cause disease in animals and humans,
especially the closely related agent of HGE, E. phagocytophila
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunity directed against MSP 2 during anaplasmosis
-
批准号:6632317
-
项目类别:
-
资助金额:$8.07万
-
财政年份:2001
-
负责人:JEFFREY R ABBOTT
-
依托单位:
Immunity directed against MSP 2 during anaplasmosis
-
批准号:6320428
-
项目类别:
-
资助金额:$6.09万
-
财政年份:2001
-
负责人:JEFFREY R ABBOTT
-
依托单位:
Immunity directed against MSP 2 during anaplasmosis
-
批准号:7060289
-
项目类别:
-
资助金额:$7.89万
-
财政年份:2001
-
负责人:JEFFREY R ABBOTT
-
依托单位:
Immunity directed against MSP 2 during anaplasmosis
-
批准号:6511337
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2001
-
负责人:JEFFREY R ABBOTT
-
依托单位:
海外基金